DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications

The marked heterogeneity of lung adenocarcinoma (LUAD) makes its diagnosis and treatment difficult. In addition, the aberrant DNA methylation profile contributes to tumor heterogeneity and alters the immune response. We used DNA methylation array data from publicly available databases to establish a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Aging (Albany NY)
Autores principales: Xu, Feng, He, Lulu, Zhan, Xueqin, Chen, Jiexin, Xu, Huan, Huang, Xiaoling, Li, Yangyi, Zheng, Xiaohe, Lin, Ling, Chen, Yongsong
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7803536/
https://ncbi.nlm.nih.gov/pubmed/33234739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.104129
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares